Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • October
  • Page 38
triple-action-iron-supplement-boosts-gut-health-and-more
Posted inBiotechnology

Triple-Action Iron Supplement Boosts Gut Health and More

October 15, 2025
Iron-deficiency anemia remains one of the most pervasive nutritional disorders worldwide, manifesting primarily through symptoms such as chronic fatigue, recurrent…
Read More
revolutionary-neural-symbolic-model-transforms-space-physics
Posted inBiotechnology

Revolutionary Neural Symbolic Model Transforms Space Physics

October 15, 2025
In a groundbreaking endeavor to harness artificial intelligence for the understanding of complex physical systems, researchers have introduced an innovative…
Read More
prostate-cancer-therapy-effectiveness-boosted-by-combination-with-enzyme-inhibition
Posted inGenetics

Prostate Cancer Therapy Effectiveness Boosted by Combination with Enzyme Inhibition

October 15, 2025
Credit: Steve Gschmeissner/Science Photo Library/Getty Images An international study led by scientists at Flinders University and at South China University…
Read More
recipharm-opens-parenteral-development-and-sterility-labs-in-india
Posted inGenetics

Recipharm Opens Parenteral Development and Sterility Labs in India

October 15, 2025
Credit: Recipharm Recipharm, a CDMO, opened its newly-commissioned parenteral development and sterility laboratories at its Bengaluru site in India. The…
Read More
multi-omics-uncover-taxane-neuropathy-insights
Posted inBiotechnology

Multi-Omics Uncover Taxane Neuropathy Insights

October 15, 2025
In the relentless battle against breast cancer, taxane-based chemotherapeutics have emerged as a frontline defense, boasting significant efficacy in halting…
Read More
boehringer-ingelheim-digs-in-on-adcs,-offering-up-to-$991m-to-license-cancer-prospect-from-korea’s-aimedbio
Posted inBiotechnology

Boehringer Ingelheim digs in on ADCs, offering up to $991M to license cancer prospect from Korea’s AimedBio

October 15, 2025
After charting several related moves earlier this year, Boehringer Ingelheim is returning to the antibody-drug conjugate well. Boehringer will pay…
Read More
eli-lilly’s-orforglipron-bests-farxiga,-padding-oral-glp-1-case-with-pair-of-phase-3-diabetes-wins
Posted inBiotechnology

Eli Lilly’s orforglipron bests Farxiga, padding oral GLP-1 case with pair of phase 3 diabetes wins

October 15, 2025
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up…
Read More
newamsterdam-partners-with-ai-based-caristo-diagnostics-on-cholesterol-drug-trial
Posted inMedical Technology

NewAmsterdam partners with AI-based Caristo Diagnostics on cholesterol drug trial

October 15, 2025
Caristo Diagnostics, which uses artificial intelligence to detect the earliest signs of heart disease on cardiac CT scans, will play…
Read More
abbott-medical-device-growth-offsets-q3-diagnostics-slide-as-covid-testing-wanes
Posted inMedical Technology

Abbott medical device growth offsets Q3 diagnostics slide as COVID testing wanes

October 15, 2025
Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in…
Read More
novo-nordisk-pens-$2.1b-deal-for-omeros’-stalled-pnh-drug
Posted inBiotechnology

Novo Nordisk pens $2.1B deal for Omeros’ stalled PNH drug

October 15, 2025
After Omeros decided to hit pause on developing its MASP-3 inhibitor zaltenibart, Novo Nordisk has spied an opportunity to scoop…
Read More

Posts pagination

Previous page 1 … 36 37 38 39 40 … 64 Next page

Privacy Policy    Terms

Scroll to Top